ClinConnect ClinConnect Logo
Search / Trial NCT07147439

Turkish Validation of the ALOC Screening Scale in Older Adults

Launched by TOROS UNIVERSITY ·

Trial Information

Current as of November 05, 2025

Not yet recruiting

Keywords

Elderly Aloc Snaq Turkish Validity And Reliability

ClinConnect Summary

This clinical trial is studying a tool called the Loss of Appetite Scale, which helps identify loss of appetite in older adults. Loss of appetite is common in people aged 65 and older and can lead to serious health issues like weight loss, poor nutrition, and weaker immune systems. This study aims to test whether the Turkish version of this scale is accurate and reliable for use with older adults, including those with memory or thinking problems like dementia or Alzheimer’s disease.

The study is looking for adults aged 65 or older, regardless of gender, who may or may not have cognitive issues. Participants will be asked to complete the appetite scale to see if it works well in Turkish-speaking older adults. This is important because having a trustworthy way to measure appetite loss can help doctors identify and address this problem early, improving overall health and quality of life for elderly individuals. The trial has not started recruiting yet, but those interested should be aware it focuses on improving care for the aging population in Turkey.

Gender

ALL

Eligibility criteria

About Toros University

Toros University is a forward-thinking academic institution dedicated to advancing medical research and education. With a commitment to innovation and excellence, the university actively engages in clinical trials that aim to enhance patient care and contribute to the broader scientific community. By fostering collaboration among researchers, healthcare professionals, and students, Toros University seeks to address pressing health challenges through rigorous scientific inquiry and the application of cutting-edge methodologies. Their comprehensive approach ensures that clinical trials not only meet regulatory standards but also prioritize participant safety and ethical considerations.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported